Phase 1/2A Study Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Carfilzomib (Primary) ; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 12 Jun 2018 Status changed from active, no longer recruiting to completed.
- 17 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.